Taiwan vaccine maker applies to conduct Phase 3 clinical trials in Paraguay

Taiwan's domestic COVID-19 vaccine producer Medigen Vaccine Biologics Corp. on Tuesday announced that it has officially applied to conduct Phase 3 clinical trials in Paraguay, Taiwan's only diplomatic ally in South America.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)